BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

175 related articles for article (PubMed ID: 1607483)

  • 21. Absence of Merkel cells in lesional skin of vitiligo [corrected].
    Bose SK
    Int J Dermatol; 1994 Jul; 33(7):481-3. PubMed ID: 7523320
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inflammatory changes in vitiligo: stage I and II depigmentation.
    Sharquie KE; Mehenna SH; Naji AA; Al-Azzawi H
    Am J Dermatopathol; 2004 Apr; 26(2):108-12. PubMed ID: 15024191
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Melanocytes are not absent in lesional skin of long duration vitiligo.
    Tobin DJ; Swanson NN; Pittelkow MR; Peters EM; Schallreuter KU
    J Pathol; 2000 Aug; 191(4):407-16. PubMed ID: 10918216
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Repigmentation of vitiliginous skin by cultured cells.
    Brysk MM; Newton RC; Rajaraman S; Plott T; Barlow E; Bell T; Penn P; Smith EB
    Pigment Cell Res; 1989; 2(3):202-7. PubMed ID: 2475866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Leukoderma induced by rhododendrol is different from leukoderma of vitiligo in pathogenesis: A novel comparative morphological study.
    Tsutsumi R; Sugita K; Abe Y; Hozumi Y; Suzuki T; Yamada N; Yoshida Y; Yamamoto O
    J Cutan Pathol; 2019 Feb; 46(2):123-129. PubMed ID: 30456919
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pigment cell transplantation for treatment of vitiligo: a progress report.
    Löntz W; Olsson MJ; Moellmann G; Lerner AB
    J Am Acad Dermatol; 1994 Apr; 30(4):591-7. PubMed ID: 8157785
    [TBL] [Abstract][Full Text] [Related]  

  • 27. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Histopathology of vitiliginous skin.
    Gokhale BB; Mehta LN
    Int J Dermatol; 1983 Oct; 22(8):477-80. PubMed ID: 6642834
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vitiligo Skin: Exploring the Dermal Compartment.
    Kovacs D; Bastonini E; Ottaviani M; Cota C; Migliano E; Dell'Anna ML; Picardo M
    J Invest Dermatol; 2018 Feb; 138(2):394-404. PubMed ID: 29024688
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vivo confocal laser scanning microscopy of hypopigmented macules: a preliminary comparison of confocal images in vitiligo, nevus depigmentosus and postinflammatory hypopigmentation.
    Xiang W; Xu A; Xu J; Bi Z; Shang Y; Ren Q
    Lasers Med Sci; 2010 Jul; 25(4):551-8. PubMed ID: 20180143
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Involvement of T cells in early evolving segmental vitiligo.
    Shin J; Kang HY; Kim KH; Park CJ; Oh SH; Lee SC; Lee S; Choi GS; Hann SK
    Clin Exp Dermatol; 2016 Aug; 41(6):671-4. PubMed ID: 27334675
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Role of hair follicles in the repigmentation of vitiligo.
    Cui J; Shen LY; Wang GC
    J Invest Dermatol; 1991 Sep; 97(3):410-6. PubMed ID: 1714927
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Melanocyte detachment after skin friction in non lesional skin of patients with generalized vitiligo.
    Gauthier Y; Cario-Andre M; Lepreux S; Pain C; Taïeb A
    Br J Dermatol; 2003 Jan; 148(1):95-101. PubMed ID: 12534601
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Involvement of non-melanocytic skin cells in vitiligo.
    Bastonini E; Bellei B; Filoni A; Kovacs D; Iacovelli P; Picardo M
    Exp Dermatol; 2019 Jun; 28(6):667-673. PubMed ID: 30582762
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vitiliginous achromia with malignant melanoma. Tyrosinase activity and ultrastructural study of achromic and normal skin.
    Perrot H; Ortonne JP; Schmitt D
    Arch Dermatol Res (1975); 1977 Jan; 257(3):247-53. PubMed ID: 402121
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical markers of vitiligo activity.
    Benzekri L; Gauthier Y
    J Am Acad Dermatol; 2017 May; 76(5):856-862. PubMed ID: 28245942
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Probable mechanisms of loss of Merkel cells in completely depigmented skin of stable vitiligo.
    Bose SK
    J Dermatol; 1994 Oct; 21(10):725-8. PubMed ID: 7798428
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Morphology of melanocytes in hair bulbs and eyes of vitiligo mice.
    Boissy RE; Moellmann GE; Lerner AB
    Am J Pathol; 1987 May; 127(2):380-8. PubMed ID: 3578491
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A surgical treatment for vitiligo: autologous cultured-epithelial grafts.
    Plott RT; Brysk MM; Newton RC; Raimer SS; Rajaraman S
    J Dermatol Surg Oncol; 1989 Nov; 15(11):1161-6. PubMed ID: 2808886
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.